VivoSeq
Other

Whole-Brain Radiotherapy

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Whole-Brain Radiotherapy is an early-stage landscape with 0 programs across 1 company. The most active players are ImmunoChem Therapeutics, LLC.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

30/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

I

ImmunoChem Therapeutics, LLC

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed3 · 30%
Terminated3 · 30%
Unknown status2 · 20%
Recruiting2 · 20%

Clinical Trials

Trial Activity

10 trials

Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Recruiting·—·Phase 3·NCT07443397·134 enrolled
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Recruiting·CCanadian Cancer Trials Group·Phase 3·NCT03550391·206 enrolled
Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment
Completed·IInstituto Nacional de Cancerologia de Mexico·Phase 2·NCT01015534·55 enrolled
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Completed·NRG Oncology·Phase 3·NCT02360215·518 enrolled
MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases
Completed·IImmunoChem Therapeutics, LLC·Phase 1·NCT05417282·27 enrolled
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
Terminated·BBioMimetix JV, LLC·Phase 1/2·NCT03608020·35 enrolled
Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
Terminated·VVanderbilt-Ingram Cancer Center·Phase 1·NCT00469937·9 enrolled
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
Terminated·NRG Oncology·Phase 3·NCT04588246·19 enrolled
A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
Unknown status·SSun Yat-sen University·Phase 2·NCT02832635·256 enrolled
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
Unknown status·ZZhejiang Cancer Hospital·Phase 1/2·NCT02385136·135 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)